Abstract:Objective To observe the curative effect of the single chain antibodies of epidermal growth factor receptor variant Ⅲ (EGFRvⅢ) single chain antibody variable fragment (EGFRvⅢ scFv) on cerebral gliomas. Methods The expression of the recombinant protein in Escherichia coli was induced by the constructed plasmid inserted into with EGFRvⅢ scFv gene whose sequence was in accordance with the one published in Gene Bank. However, the single chain functional antibodies of EGFRvⅢ scFv were identified by SDS-PAGE and western blotting, and then obtained by purification and refolding. The affinity constant of the single chain antibody was determined by enzyme linked immunosorbent assay and then the antibodies were stereotaxically injected into the brain in the mice with brain gliomas. The median survival time of the mice with brain gliomas was observed and the expression of vascular endothelial growth factor (VEGF) was determined by immunohistochemical technique. Results The double digestion and gene sequencing proved that the sequence of the synthesized GFRvⅢ scFv was in accord with Gene bank. The recombinant protein in Escherichia coli was expressed in the inclusion body form. The molecular weight of the protein was 63 kDa which was in accordance with the expected value. The affinity constant was 0.203×10-8 mol/L. The level of VEGF expression in the tumors was significantly lower (P<0.05) and the median survival time of the mice with tumors was significantly longer (P<0.01) in the experimental group than those in the control group. Conclusions The expression plasmid of pET30a-EGFRvⅢ scFv is successfully constructed. The recombinant protein of EGFRvⅢ scFv after the purification and refolding is capable of specific binging to EGFRvⅢ. The expression of VEGF in the gliomas may be decreased and the median survival time of the mice with gliomas was prolonged by the intracerebral injection of EGFRvⅢ scFv.

Preparation of Molecular Targeting Toxins Against Glioma and Study on Their Biological Characters

Preparation of Single Chain Antibody by Gene Engineering and Preliminary Study on Its Anti-Tumor Activity Against Glioma

Construction and Expression of Anti-Glioma Single-Chain Fv/human Tumor Necrosis Factor Α Fusion Gene

An Interesting Design of Fusion Protein to Kill Glioma Cell Line of U-87 MG Cells

The Construction of Anti-EGFR Single Chain Variable Fragment Fused with Gelonin Toxin Prokaryotic Expressing Plasmid and the Study of Its Anti-tumor Effects

Targeted Killing Effect of IL-13 Diphtheria Toxin Fusion Protein and DT_(389)-hIL13-13E13K

Study on the Expression and Immune Enhancement of IL-18-GPI Fused Protein

Preparatipn and Activity Assay of Anti-carcinoma ScFv Immunotoxin

DC-tumor cell fusion for induction of tumor-specific T-cell response against malignant brain tumors

Synthesis and purification of a toxin-linked conjugate targeting epidermal growth factor receptor in Escherichia coli.

Cell-Targeting Fusion Constructs Containing Recombinant Gelonin

PRELIMINARY STUDIES ON INTERLEUKIN-2-PSEUDOMONAS EXOTOXIN FUSION PROTEINS, IL-2-PE40 AND IL-2-PE66(4GLU)

Synthesis and characterization of novel nonviral vectors for tumor- targeted gene delivery to C6 glioma cells in vitro

Chlorotoxin fusion protein regulates miR-374a and TNFAIP8 expression and inhibits glioma cell proliferation and promotes apoptosis

Inhibition of Cell Proliferation, Migration and Invasion by A Glioma-Targeted Fusion Protein Combining the P53 C Terminus and Mdm2-Binding Domain

Curative effect of Single chain antibodies of EGFRvⅢ on brain gliomas in mice

An Efficient Scheme for Purification of a Novel Recombinant Immunotoxin, Rcck8pe38, for Anti-Tumour Experiments.

Construction of Eukaryotic Expression Plasmid Pegfp-N3-m-il-2(88 Arg,125 Ala) and Its Effects on Glioma Cell Line U87

Construction and Expression of a Recombinant Immunotoxin Against Human Glioma, SZ39(ScFv)-PE40

Enhanced Glioma-Targeting and Stability of LGICP Peptide Coupled with Stabilized Peptide DA7R

Prokaryotic Expression, Purification of HSP65-MUC1 VNTR2 Fusion Protein and Primary Research on Its Tumoricidal Effect